Pharmacology

An expert examines upcoming regulations

The platform technology, in which specific antigens are expressed by genetically modified yeast cells, was developed by the research and development team of Germany-based serYmun Yeast GmbH.

The pour-on NSAID for cattle is now FDA-approved for control of fever with mastitis

The therapy is an antiparasitic drug that contains the same active ingredient as Dectomax.

We have compiled a countdown of our top 20 articles in 2022, here is number 1

Appropriate management can help control the clinical signs and improve equine quality of life

Advances in technology reduce inefficiencies, saving time and money

Veterinary tranquilizer does not respond to opioid-reversing drugs like naloxone, contributing to an increase in overdose deaths

A boarded oncologist provides insight into how affordable, older medications can open the door to alternative options for managing these diseases

The bexagliflozin product (Bexacat; Increvet Inc) is also the first SGLT2 inhibitor new animal drug approved by the FDA in any animal species.

Melissa King, PharmD, explains the difference between beyond-use dates and expiration dates and how upcoming USP changes may impact inventory

Ingesting of human psychiatric drugs can cause clinical signs ranging from sympathomimetic to anticholinergic

How to navigate the transition from beyond-use dates to expiration dates

Leatha Lynch will ensure the state and federal regulatory compliance of prescription medications and diets dispensed out of the company's west and east coast locations

How virtual care is changing the landscape of veterinary medicine

Electronic prescribing finally comes to veterinary medicine

Toxic ingestions of human psychiatric drugs can cause clinical signs in pets that range from sympathomimetic to anticholinergic.

The first-of-its-kind product from Merck Animal Health provides 2-in-1 coverage against canine parainfluenza virus and Bordetella bronchiseptica

Both fluralaner topical solution (Bravecto) and fluralaner and moxidectin topical solution (Bravecto Plus) are now indicated for the treatment and control of Asian longhorned tick infestations in cats.

The product from Boehringer Ingelheim promotes the development of antibodies against rotavirus, coronavirus, and E. coli F5 (K99) adhesin

These tablets will help treat pain and inflammation in connection to osteoarthritis in equine patients

Study will focus on effects of CBD and CBG for canine elbow osteoarthritis

Wedgewood Connect has received a license to offer veterinarians office-use compounds in New York

A recent study sought to identify, understand, and solve potential medication errors related to veterinary prescriptions.

Pharmaceutical sponsors who meet the eligibility requirements or their research partners are encouraged to apply.